A $45 million financing package by the US International Development Finance Corporation (DFC), the African Development Bank (AfDB), and the International Finance Corporation (IFC) aims to strengthen vaccine production in Africa. The investment supports VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). It aims to enhance local vaccine manufacturing by expanding the capacity of the IPD’s MADIBA facility. Among other things, the investment will boost vaccine production capacity, support local supply chains, and set up a vaccine distribution system. The investment’s goals align with the African Union’s Vision 2040, which seeks to produce 60% of Africa’s vaccines locally, reducing reliance on imports. Beyond improving public health, the initiative is expected to create jobs, boost economic growth, and address critical gaps in vaccine supply chains.
SOURCE: NAIRAMETRICS
